3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHFBunyaviridae infectious disease, Crimean-Congo hemorrhagic fever, Infections, RNA Virus Infections, arbovirus infection, tick-borne infectious disease, vector-borne disease, viral hemorrhagic fever, viral infectious diseaseRecruitingPhase 22026-08-07NCT06860334
Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-CareBunyaviridae infectious disease, Crimean-Congo hemorrhagic fever, Infections, RNA Virus Infections, arbovirus infection, tick-borne infectious disease, vector-borne disease, viral hemorrhagic fever, viral infectious diseaseRecruitingNot applicable2026-06-09NCT06624787
Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).metabolic dysfunction-associated steatotic liver diseaseNot yet recruitingNot stated2026-02-24NCT07430501